In the current report, a decrease of anti-apoptotic MCL-1 was observed in most AML cells tested, while an increase of pro-apoptotic BH3-only proteins, predominantly BIM, was observed in other cell lines. This evidence concerns the gene BCL2L11 and acute myeloid leukemia.